Ying Zou Selected Research

Catenins

1/2021	MicroRNA-21 released from mast cells-derived extracellular vesicles drives asthma in mice by potentiating airway inflammation and oxidative stress.
1/2018	DDX39 promotes hepatocellular carcinoma growth and metastasis through activating Wnt/β-catenin pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying Zou Research Topics

Disease

32	Neoplasms (Cancer) 03/2024 - 01/2003
16	Inflammation (Inflammations) 02/2024 - 01/2014
8	Ulcerative Colitis 03/2016 - 04/2012
7	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 05/2007
6	Colorectal Neoplasms (Colorectal Cancer) 02/2022 - 03/2015
6	Colitis 01/2021 - 01/2014
5	Breast Neoplasms (Breast Cancer) 11/2021 - 10/2016
5	Endometriosis 01/2013 - 09/2009
4	Insulin Resistance 01/2024 - 01/2018
4	Neoplasm Metastasis (Metastasis) 11/2023 - 03/2015
4	Stomach Neoplasms (Stomach Cancer) 01/2023 - 07/2017
3	Cognitive Dysfunction 01/2024 - 01/2019
3	Liver Neoplasms (Liver Cancer) 11/2023 - 01/2023
3	Atopic Dermatitis (Atopic Eczema) 10/2023 - 01/2022
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2021
3	Melanoma (Melanoma, Malignant) 01/2023 - 12/2016
3	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 12/2022 - 04/2018
3	Obesity 12/2022 - 09/2021
3	Alzheimer Disease (Alzheimer's Disease) 10/2022 - 01/2019
3	Pain (Aches) 04/2022 - 08/2017
3	Hypersensitivity (Allergy) 01/2022 - 03/2016
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 01/2015
3	Hypoxia (Hypoxemia) 01/2019 - 10/2003
3	Carcinogenesis 12/2016 - 01/2013
2	Retinoblastoma (Glioblastoma, Retinal) 04/2024 - 12/2018
2	Hemorrhage 03/2024 - 01/2015
2	Type 2 Diabetes Mellitus (MODY) 01/2024 - 01/2018
2	Liver Diseases (Liver Disease) 12/2023 - 11/2023
2	Fatty Liver 12/2023 - 11/2023
2	Osteoarthritis 10/2023 - 01/2017
2	Lung Neoplasms (Lung Cancer) 08/2023 - 12/2004
2	Ischemia 01/2023 - 05/2003
2	Retinal Vein Occlusion 01/2023 - 10/2019
2	Atrophy 01/2023 - 01/2022
2	Dyslipidemias (Dyslipidemia) 12/2022 - 01/2022
2	Hypertension (High Blood Pressure) 03/2022 - 02/2006
2	Bites and Stings (Sting) 01/2022 - 01/2020
2	Anxiety Disorders (Anxiety Disorder) 01/2022 - 04/2012
2	Carcinoma (Carcinomatosis) 01/2022 - 08/2021
2	Pneumonia (Pneumonitis) 01/2022 - 05/2016
2	Ovarian Neoplasms (Ovarian Cancer) 11/2021 - 01/2020
2	Disease Progression 01/2021 - 12/2020
2	COVID-19 10/2020 - 09/2020
2	Contact Dermatitis (Eczema, Contact) 08/2020 - 04/2012
2	Body Weight (Weight, Body) 01/2020 - 04/2005
2	Weight Loss (Weight Reduction) 01/2020 - 10/2015
2	Overweight 01/2020 - 01/2018
2	Retinal Neovascularization 10/2019 - 04/2005
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 10/2016
2	Non-alcoholic Fatty Liver Disease 01/2019 - 01/2018
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 08/2017 - 12/2014
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2017 - 12/2016
2	Genomic Instability 01/2017 - 10/2014

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2003
7	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2018
7	CytokinesIBA 11/2023 - 01/2013
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2016
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2019 - 10/2003
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2014
5	baicalinIBA 10/2015 - 04/2012
4	MicroRNAs (MicroRNA)IBA 06/2022 - 10/2016
4	LipidsIBA 01/2022 - 01/2018
4	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2017 - 05/2004
4	His(5)-Trp(7)-Tyr(8)- LHRHIBA 01/2013 - 09/2009
3	CurcuminIBA 04/2024 - 09/2017
3	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2023
3	FlavonoidsIBA 01/2024 - 01/2014
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2023 - 10/2014
3	dupilumabIBA 10/2023 - 01/2021
3	Transcription Factors (Transcription Factor)IBA 01/2023 - 04/2015
3	Immunoglobulin E (IgE)IBA 01/2023 - 01/2018
3	fibrin fragment D (D-dimer)IBA 03/2022 - 05/2016
2	ORALIT (ORS)IBA 03/2024 - 10/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2024 - 03/2022
2	didyminIBA 01/2024 - 12/2023
2	Insulin (Novolin)FDA Link 01/2024 - 01/2018
2	Nonesterified Fatty Acids (NEFA)IBA 01/2024 - 01/2018
2	Oxygen (Dioxygen)IBA 01/2024 - 04/2005
2	Phosphotransferases (Kinase)IBA 11/2023 - 03/2016
2	Retinaldehyde (Retinal)IBA 01/2023 - 10/2019
2	AllergensIBA 01/2023 - 08/2020
2	Metformin (Glucophage)FDA LinkGeneric 12/2022 - 09/2021
2	Blood Glucose (Blood Sugar)IBA 12/2022 - 01/2022
2	Gefitinib (Iressa)FDA Link 01/2022 - 01/2021
2	Mitochondrial DNA (mtDNA)IBA 01/2022 - 01/2016
2	InterferonsIBA 01/2022 - 01/2020
2	Shen-FuIBA 01/2022 - 01/2021
2	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2013
2	Dextran SulfateIBA 01/2021 - 01/2014
2	CateninsIBA 01/2021 - 01/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2020 - 11/2014
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020 - 10/2016
2	ChitosanIBA 01/2020 - 01/2018
2	LycopeneIBA 08/2017 - 12/2014

Therapy/Procedure

22	Therapeutics 02/2024 - 05/2004
6	Drug Therapy (Chemotherapy) 03/2024 - 01/2016
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 12/2016
3	Aftercare (After-Treatment) 05/2021 - 01/2019
2	Lasers (Laser) 05/2021 - 10/2003
2	Perioperative Period 04/2018 - 03/2015